NEULAND LAB on NSE is at a significant pivot point where it has closed above the 50 DEMA,
The Stock has had pullback above @ 38.2% of its previous impulse indicating a trend continuation.
A CHange of Character(CHoCh) at daily price close above 6450, this is good entry point with a first target of 7100 (10% gain)to traverse the downward gap of 300 Rs. in the last downward impulse.
There has been consistent buying for the past 3 weeks but just below 20Volume MA.
Price has closed above 38.2% FIBO.
RSI on WEEKLY is at 40
Keep a SL of 6220 the Previous week low, set a Target 1 of 7100 (Gap Close) and Target 2 of 7750 for a (20% gain) the previous Swing High.
support at 5900-6100 lvl
Can add quantity as per risk appetite above the 61.8% pullback FIBO of 6914.
The Stock has had pullback above @ 38.2% of its previous impulse indicating a trend continuation.
A CHange of Character(CHoCh) at daily price close above 6450, this is good entry point with a first target of 7100 (10% gain)to traverse the downward gap of 300 Rs. in the last downward impulse.
There has been consistent buying for the past 3 weeks but just below 20Volume MA.
Price has closed above 38.2% FIBO.
RSI on WEEKLY is at 40
Keep a SL of 6220 the Previous week low, set a Target 1 of 7100 (Gap Close) and Target 2 of 7750 for a (20% gain) the previous Swing High.
support at 5900-6100 lvl
Can add quantity as per risk appetite above the 61.8% pullback FIBO of 6914.
Trade active
Entry Triggered @6450 #NEULANDLAB on NSETrade active
Target 1 Touched....Note
TGT 2 ACHIEVED HOLDNote
KEEP SL 8001 and HOLDTrade active
A good 6.3% move today 30JulMove SL to 8400, TGT 9150 and Hold to 10000,
Trade active
Maintain SL at 10600Trade closed: target reached
TARGET REACHEDTrade closed manually
Multiple Rejection @12500 Exit
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.